©2023-2035
All Rights Reserved. Online Journal of Veterinary Research.
You may not store these pages in any form except for your own personal use. All
other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the
before mentioned must be gained in writing from the publisher. This
article is exclusively copyrighted in its entirety to onlinejournals@gmail.com
publications.. This article may be copied once but may
not be, reproduced or re-transmitted without the
express permission of the editors. Linking: To link to this page or any pages
linking to this page you must link directly to this page only here rather than
put up your own page.
OJVRTM
Online
Journal of Veterinary Research©
(Including Medical and Laboratory Research)
Established 1994
ISSN 1328-925X
Volume
28 (9): 558-565, 2024.
Gene
microarray expression analysis targets for tuberculosis.
Anu Rastogi, Pallavi Gangwar, Ankur Mohan, Santosh
Kumar, Abhishek Malakar
Amity University, Noida, BCS-InSilico
Biology, Lucknow, U.P, National Bureau of Fish Genetic Resources, Lucknow, U.P,
India.
ABSTRACT
Rastogi A, Gangwar P, Mohan A, Kumar S, Malakar
A., Gene microarray expression analysis targets for tuberculosis, Onl
J Vet Res., 28
(9): 558-565, 2024. Hierarchical and k means
clustering methods have been used for the analysis of microarray gene
expression data of Mycobacterium
Tuberculosis. By microarray we found that IFNA2 and IFNB1 genes had slight
different expressions to yield 20 genes relevant to tuberculosis from 6
clusters from 52 datasets. By phylogenetic analysis INS-IGF2 and TNP2 proteins
were generated and structure of ICS-IGF2 was modeled for docking ligands of -15.3
K/cal/mol for binding compared
to -13.5 K/cal/mol from Drugbank. Our findings suggest our proteins may bind more
strongly compared with current tuberculosis drugs. By co-expression, we
generated INS- IGF2 and TNP2 gene targets in Mycobacterium Tuberculosis.
Keywords: Mycobacterium
tuberculosis, microarrays, phylogenetic,
binding, drug targets.
FULL-TEXT (SUBSCRIBE OR PURCHASE
TITLE)